BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

435 hedge funds and large institutions have $11.7B invested in BioMarin Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 170 increasing their positions, 161 reducing their positions, and 79 closing their positions.

Holders
435
Holders Change
-46
Holders Change %
-9.56%
% of All Funds
9.55%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.2%
New
35
Increased
170
Reduced
161
Closed
79
Calls
$81.3M
Puts
$112M
Net Calls
-$30.6M
Net Calls Change
+$31.6M

Top Buyers

1
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.46B
2
Primecap Management
2
Primecap Management
California
$1.02B
3
Capital International Investors
3
Capital International Investors
California
$173M
4
Citadel Advisors
4
Citadel Advisors
Florida
$118M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.11B

Top Sellers

1
Nuveen Asset Management
1
Nuveen Asset Management
Illinois
$86.2M
2
Jennison Associates
2
Jennison Associates
New York
$562M
3
WRF
3
Waddell & Reed Financial
Kansas
$0
4
HCM
4
Highline Capital Management
New York
$0
5
PAMU
5
Pictet Asset Management (UK)
United Kingdom
$39.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.46B 21,707,664 +2,011,459 +10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.11B 16,482,444 +524,772 +3%
Primecap Management
3
Primecap Management
California
$1.02B 15,162,074 +878,321 +6%
BlackRock
4
BlackRock
New York
$870M 12,900,713 +40,642 +0.3%
Jennison Associates
5
Jennison Associates
New York
$562M 8,331,400 -1,116,415 -12%
BBA
6
Baker Bros. Advisors
New York
$512M 7,589,294 – –
ClearBridge Investments
7
ClearBridge Investments
New York
$407M 6,042,714 +68,440 +1%
Sands Capital Management
8
Sands Capital Management
Virginia
$375M 5,565,620 -166,343 -3%
State Street
9
State Street
Massachusetts
$329M 4,875,782 +186,442 +4%
Viking Global Investors
10
Viking Global Investors
Connecticut
$206M 3,058,104 +467,753 +18%
Ameriprise
11
Ameriprise
Minnesota
$195M 2,891,622 +3,229 +0.1%
Capital International Investors
12
Capital International Investors
California
$173M 2,565,783 +764,300 +42%
Capital World Investors
13
Capital World Investors
California
$168M 2,491,786 +65,704 +3%
ACA
14
Avoro Capital Advisors
New York
$164M 2,437,100 +322,100 +15%
Temasek Holdings
15
Temasek Holdings
Singapore
$160M 2,372,712 – –
Invesco
16
Invesco
Georgia
$152M 2,248,162 -597,674 -21%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$151M 2,244,321 -51,883 -2%
PAI
18
Palo Alto Investors
California
$149M 2,209,504 -396,981 -15%
PHS
19
PFM Health Sciences
California
$145M 2,149,051 +69,663 +3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$123M 1,828,200 +21,321 +1%
Citadel Advisors
21
Citadel Advisors
Florida
$118M 1,757,230 +587,616 +50%
Bank of America
22
Bank of America
North Carolina
$107M 1,592,010 -257,231 -14%
Norges Bank
23
Norges Bank
Norway
$102M 1,507,703 -229,622 -13%
Goldman Sachs
24
Goldman Sachs
New York
$99.1M 1,469,604 -498,011 -25%
Nuveen Asset Management
25
Nuveen Asset Management
Illinois
$86.2M 1,279,476 -1,733,420 -58%
1
2 3 4 5